Article Details
Retrieved on: 2022-11-03 15:42:58
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... three of Catalent's target programs with antibody and ADC candidates. ... ADCs with monoclonal antibodies from Exelixis' preclinical pipeline.
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here